ArticleNorthern clinics of Istanbul2022

Ranibizumab therapy for predominantly hemorrhagic neovascular age-related macular degeneration.

Ozlem Dikmetas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.